Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 11, 2010 08:30 ET | Source: Immunomedics, Inc.

Immunomedics' Product Candidates to be Presented at the 52nd ASH Annual Meeting

MORRIS PLAINS, N.J., Nov. 11, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the...
November 09, 2010 08:00 ET | Source: Immunomedics, Inc.

Epratuzumab Phase IIB Data Presented at ACR Show

Epratuzumab reduced disease activity in adult patients with moderate to severe active systemic lupus erythematosus (SLE)1 Reduced disease activity observed as early as week 8, with further...
November 04, 2010 08:30 ET | Source: Immunomedics, Inc.

Immunomedics Announces First Quarter Fiscal 2011 Results and Clinical Program Developments

MORRIS PLAINS, N.J., Nov. 4, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the...
November 02, 2010 15:10 ET | Source: Immunomedics, Inc.

Immunomedics Awarded 12 Qualifying Therapeutic Discovery Project Grants

MORRIS PLAINS, N.J., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the...
October 28, 2010 08:30 ET | Source: Immunomedics, Inc.

Immunomedics to Present at Upcoming Healthcare Conferences

MORRIS PLAINS, N.J., Oct. 28, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the...
October 12, 2010 08:30 ET | Source: Immunomedics, Inc.

Immunomedics Awarded Additional U.S. Patent for Antibody Therapy of Autoimmune Diseases

MORRIS PLAINS, N.J., Oct. 12, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the...
October 08, 2010 08:30 ET | Source: Immunomedics, Inc.

Immunomedics to Webcast October 15th R&D Day

MORRIS PLAINS, N.J., Oct. 8, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the...
September 15, 2010 08:30 ET | Source: Immunomedics, Inc.

Immunomedics to Present at 2010 UBS Global Life Sciences Conference

MORRIS PLAINS, N.J., Sept. 15, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for...
August 26, 2010 16:00 ET | Source: Immunomedics, Inc.

Immunomedics Announces Fiscal 2010 Results

MORRIS PLAINS, N.J., Aug. 26, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the...
August 18, 2010 10:30 ET | Source: Immunomedics, Inc.

Immunomedics and GE Healthcare in Research Collaboration

MORRIS PLAINS, N.J. and CHALFONT ST. GILES, UK, Aug. 18, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) and GE Healthcare, a business unit of General Electric Company (NYSE:GE), announced...